CME

Description
There has been a resurgence of investigation into the biology of mitochondria. In particular, recent advances in proteomics and imaging technologies have markedly enhanced our understanding pertaining to the molecular and biochemical functioning of mitochondria. This knowledge has, in turn, lead to the realization that the regulation of mitochondrial function, turnover, and content affects various physiological systems.

This conference will bring together leading thinkers in the field of mitochondrial biology to review the most current knowledge of the mitochondrial regulatory program and its role in cardiovascular health and disease.

Who Should Attend
This activity is intended for scientists, physicians, and pharmacologists with an interest in mitochondrial biology, genetics and therapeutics for application in the cardiovascular field.

Objective
After attending this activity, the participants should be able to discuss and explain current advances in the understanding of mitochondrial biology and function at the molecular and biochemical levels. They will also discuss the role of mitochondrial biology in cardiovascular health and disease. Participants will be able to apply these advances to explore the application of novel therapeutics targeting mitochondrial function to modulate cardiac risk factors and treat cardiovascular disease. In addition, researchers will be able to propose collaborative relationships with other health professionals who share an interest in pursuing novel applications in this emerging field.

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The Johns Hopkins University School of Medicine and The National Institutes of Health. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 13 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Speaker and Provider Disclosure
It is the policy of The Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.

The Johns Hopkins University School of Medicine takes responsibility for the content, quality and scientific integrity of this CME activity.